SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009415
Filing Date
2017-05-08
Accepted
2017-05-08 16:28:20
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20170331.htm 10-Q 1341731
2 EX-31.1 dvax-ex311_7.htm EX-31.1 17953
3 EX-31.2 dvax-ex312_8.htm EX-31.2 17872
4 EX-32.1 dvax-ex321_6.htm EX-32.1 6080
5 EX-32.2 dvax-ex322_9.htm EX-32.2 6141
  Complete submission text file 0001564590-17-009415.txt   5339281

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20170331.xml EX-101.INS 1179159
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20170331.xsd EX-101.SCH 36384
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20170331_cal.xml EX-101.CAL 43166
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20170331_def.xml EX-101.DEF 138993
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20170331_lab.xml EX-101.LAB 328160
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20170331_pre.xml EX-101.PRE 252488
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 17822824
SIC: 2834 Pharmaceutical Preparations